We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Test Selectively Identifies Influenza A Virus H1N1

By LabMedica International staff writers
Posted on 11 May 2009
A test that has been developed for the new variant of the influenza A virus H1N1 will be launched initially in Europe and Asia.

TIB Molbiol (Berlin, Germany), a cooperation partner of Roche Applied Science (Indianapolis, IN, USA), announced that the company's LightMix A test has been optimized for Roche LightCycler 480 II, 2.0, and 1.2 systems and selectively identifies the new Influenza A H1N1 virus.

"We are proud of our contribution in the battle against a potential pandemic. More...
The new test proved its suitability this week, after identifying the virus in sample materials from Mexico," said Olfert Landt, TIB Molbiol.

Currently, there is no human vaccine on the market that protects against infection by influenza A virus H1N1. Standard therapy for the disease includes treatment with antiviral drugs such as Tamiflu or Relenza.

TIB Molbiol offers custom synthesis of oligonucleotides to a growing number of customers worldwide and is one of the first suppliers of synthetic DNA on the European market. The core competence of the company lies in the development of real-time polymerase chain reaction (RT-PCR) assays for medical diagnostics, life science research, and environmental analysis.

Related Links:
TIB Molbiol
Roche Applied Science


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.